Iminect 500mg Injection is a sterile, intravenous formulation combining Imipenem 500mg and Cilastatin 500mg, designed for the treatment of serious bacterial infections. Imipenem is a broad-spectrum carbapenem antibiotic effective against a wide range of Gram-positive and Gram-negative aerobic and anaerobic pathogens. Cilastatin is a renal dehydropeptidase inhibitor that prevents the enzymatic degradation of Imipenem in the kidneys, thereby enhancing its therapeutic efficacy and prolonging its half-life. Iminect 500mg Injection is indicated for the management of complicated intra-abdominal infections, urinary tract infections, skin and soft tissue infections, respiratory tract infections, and septicemia caused by susceptible organisms. The combination ensures optimal antibacterial activity by maintaining adequate Imipenem concentrations in the bloodstream. Administration should be performed intravenously with appropriate dilution and infusion over a recommended duration to minimize potential adverse effects. Common side effects may include nausea, vomiting, diarrhea, rash, and hypersensitivity reactions. Caution is advised in patients with a history of seizures or renal impairment. Iminect 500mg Injection should be used under strict medical supervision, with dosage adjustments based on renal function and infection severity to achieve maximal therapeutic benefit while minimizing toxicity.